Rigel Pharmaceuticals, Inc. earnings per share and revenue

RIGL earnings per share for the last quarter are 0.00 USD whereas the estimation was -0.02 USD which accounts for 100.00% surprise. Företagets omsättning för samma period uppgår till 35.79 M USD trots den uppskattade siffran 34.10 M USD. Estimated earnings per share for the next quarter are -0.03 USD, and revenue is expected to reach 31.47 M USD. Also watch annual changes over time to get a bigger picture of RIGL earnings per share and revenue dynamics.